MTOR and cancer: As revealed by The Cancer Genome Atlas (TCGA) database analyses, mutations in the PI3K-mTOR pathway are dysregulated overall in a large number of cancers, and its importance for different cellular roles is critical in carcinogenesis, which justifies its use as an appealing target for drug invention [23].